Watkins J C, Krogsgaard-Larsen P, Honoré T
Department of Pharmacology, School of Medical Sciences, University Walk, Bristol.
Trends Pharmacol Sci. 1990 Jan;11(1):25-33. doi: 10.1016/0165-6147(90)90038-a.
Development of new selective ligands for excitatory amino acid receptors has been fundamental in supporting this rapidly developing field. Some of the most important ligands have come from the laboratories of Jeff Watkins, Povl Krogsgaard-Larsen and Tage Honoré, who collaborate in this double-length review to describe the chemical features and SARs of agonists and antagonists, particularly those features associated with subtype selectivity.
开发新型兴奋性氨基酸受体选择性配体对于支持这一快速发展的领域至关重要。一些最重要的配体来自杰夫·沃特金斯、波夫·克罗格斯加德-拉森和 Tage Honoré 的实验室,他们在这篇双倍篇幅的综述中合作描述了激动剂和拮抗剂的化学特征及构效关系,特别是那些与亚型选择性相关的特征。